Skip to main content

Advertisement

Table 1 Clinical features of AIS and LPA in the cohort1 and 2

From: Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma

Factors c1 c2
  AIS LPA AIS LPA
Sex     
 Male 7 2 5 13
 Female 3 8 11 12
Age     
 ≤60 3 3 7 4
 >60 7 7 9 21
Smoking     
 No 9 8 16 12
 Yes 1 2 0 13
Location     
 Peripheral 10 8 16 19
 Central 0 2 0 6
Surgical procedure     
 Lobectomy 10 10 16 24
 Pneumonectomy 0 0 0 1
laterality     
 Left 5 4 10 9
 Right 5 6 6 16
p N status     
 N0 10 10 16 16
 N1 0 0 0 6
 N2 0 0 0 3
pT status     
 T1 10 8 16 15
 T2-3 0 2 0 10
  1. c1: Clinical-pathological characteristics of the 10 patients with AIS and LPA used for cDNA microarray analysis.
  2. c2: Clinical-pathological characteristics of the 41 patients in the validation cohort.